Report on the International Workshop ‘Cancer stem cells: The mechanisms of radioresistance and biomarker discovery’

References

• Ahmed KM, Zhang H, Park CC. 2013. NF-κB regulates radioresistance mediated by β1-integrin in three-dimensional culture of breast cancer cells. Cancer Res 73:3737–3748.
   Google Scholar
• Alexander S, Weigelin B, Winkler F, Friedl P. 2013. Preclinical intravital microscopy of the tumour-stroma interface: invasion, metastasis, and therapy response. Curr Opin Cell Biol 5:659–671.
   Google Scholar
• Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD, Herold CI, Marcom PK, George DJ, Garcia-Blanco MA. 2011. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res 9:997–1007.
   PubMed Web of Science ®Google Scholar
• Attarha S, Andersson S, Mints M, Souchelnytskyi S. 2013. Individualised proteome profiling of human endometrial tumours improves detection of new prognostic markers. Br J Cancer 109:704–713.
   PubMed Web of Science ®Google Scholar
• Avoranta ST, Korkeila EA, Syrjänen KJ, Pyrhönen SO, Sundström JT. 2012. Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence. World J Gastroenterol 18:4549–4556.
   Google Scholar
• Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, Klein C, Saini M, Bäuerle T, Wallwiener M, Holland-Letz T, Höfner T, Sprick M, Scharpff M, Marmé F, Sinn HP, Pantel K, Weichert W, Trumpp A. 2013. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol 31: 539–544.
   PubMed Web of Science ®Google Scholar
• Baccelli I, Trumpp A. 2012. The evolving concept of cancer and metastasis stem cells. J Cell Biol 198:281–293.
   PubMed Web of Science ®Google Scholar
• Badeaux MA, Jeter CR, Gong S, Liu B, Suraneni MV, Rundhaug J, Fischer SM, Yang T, Kusewitt D, Tang DG. 2013. In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals. Cell Cycle 12:2395–2408.
   PubMed Web of Science ®Google Scholar
• Baumann M, DuBois W, Pu A, Freeman J, Suit HD. 1992. Response of xenografts of human malignant gliomas and squamous cell carcinomas to fractionated irradiation. Int J Radiat Oncol Biol Phys 23:803–809.
   PubMed Web of Science ®Google Scholar
• Baumann M, Krause M, Hill R. 2008. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 8:545–554.
   PubMed Web of Science ®Google Scholar
• Bianchi-Smiraglia A, Paesante S, Bakin AV. 2013. Integrin β5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways. Oncogene 32:3049–3058.
   Google Scholar
• Bidard FC, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Generali D, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, De Mattos-Arruda L, Ignatiadis M, Lebofsky R, van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki E, Consoli F, Bottini A, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C, Rutten A, Janni W, Munzone E, Carañana V, Agelaki S, Almici C, Dirix L, Solomayer EF, Zorzino L, Johannes H, Reis-Filho JS, Pantel K, Pierga JY, Michiels S. 2014. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: A pooled analysis of individual patient data. Lancet Oncol 15: 406–414.
   PubMed Web of Science ®Google Scholar
• Brunner TB, Kunz-Schughart LA, Grosse-Gehling P, Baumann M. 2012. Cancer stem cells as a predictive factor in radiotherapy. Semin Radiat Oncol 22:151–174.
   Google Scholar
• Bütof R, Dubrovska A, Baumann M. 2013. Clinical perspectives of cancer stem cell research in radiation oncology. Radiother Oncol 108:388–396.
   PubMed Web of Science ®Google Scholar
• Cartellieri M, Bachmann M, Feldmann A, Bippes C, Stamova S, Wehner R, Temme A, Schmitz M. 2010. Chimeric antigen receptor-engineered T cells for immunotherapy of cancer. J Biomed Biotechnol 956304.
   Google Scholar
• Chaudary N, Hill RP. 2009. Increased expression of metastasis-related genes in hypoxic cells sorted from cervical and lymph nodal xenograft tumors. Lab Invest 89:587–596.
   Google Scholar
• Chen X, Rycaj K, Liu X, Tang DG. 2013. New insights into prostate cancer stem cells. Cell Cycle 12:579–586.
   PubMed Web of Science ®Google Scholar
• Cheng L, Ramesh AV, Flesken-Nikitin A, Choi J, Nikitin AY. 2010. Mouse models for cancer stem cell research. Toxicol Pathol 38:62–71.
   Google Scholar
• Cojoc M, Peitzsch C, Trautmann F, Polishchuk L, Telegeev GD, Dubrovska A. 2013. Emerging targets in cancer management: Role of the CXCL12/CXCR4 axis. Onco Targets Ther. 6:1347–1361.
   PubMedGoogle Scholar
• Cui X, Oonishi K, Tsujii H, Yasuda T, Matsumoto Y, Furusawa Y, Akashi M, Kamada T, Okayasu R. 2011. Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays. Cancer Res;71:3676–3687.
   PubMed Web of Science ®Google Scholar
• Ding L, Poser I, Paszkowski-Rogacz M, Buchholz F. 2012. From RNAi screens to molecular function in embryonic stem cells. Stem Cell Rev 8:32–42.
   Google Scholar
• Economopoulou M, Masjkur J, Raiskup F, Ebermann D, Saha S, Karl MO, Funk R, Jaszai J, Chavakis T, Ehrhart-Bornstein M, Pillunat LE, Kunz-Schughart L, Kurth I, Dubrovska A, Androutsellis-Theotokis A. 2014. Expression of the transcription factor Hes3 in the mouse and human ocular surface, and in pterygium. Int J Radiat Biol 90:700–709.
   Web of Science ®Google Scholar
• Eke I, Deuse Y, Hehlgans S, Gurtner K, Krause M, Baumann M, Shevchenko A, Sandfort V, Cordes N. 2012a. β1Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. J Clin Invest 122:1529–1540.
   PubMed Web of Science ®Google Scholar
• Eke I, Dickreuter E, Cordes N. 2012b. Enhanced radiosensitivity of head and neck squamous cell carcinoma cells by β1 integrin inhibition. Radiother Oncol 104:235–242.
   Google Scholar
• Evans SM, Koch CJ. 2003. Prognostic significance of tumor oxygenation in humans. Cancer Lett 195:1–16.
   PubMedGoogle Scholar
• Fokas E, Im JH, Hill S, Yameen S, Stratford M, Beech J, Hackl W, Maira SM, Bernhard EJ, McKenna WG, Muschel RJ. 2012b. Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature. Cancer Res 72:239–248.
   PubMed Web of Science ®Google Scholar
• Fokas E, McKenna WG, Muschel RJ. 2012a. The impact of tumor micro- environment on cancer treatment and its modulation by direct and indirect antivascular strategies. Cancer Metastasis Rev 31:823–842.
   PubMed Web of Science ®Google Scholar
• Friedl P, Locker J, Sahai E, Segall JE. 2012. Classifying collective cancer cell invasion. Nat Cell Biol 14:777–783.
   PubMed Web of Science ®Google Scholar
• Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, Hill RP. 2002. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 20:680–687.
   PubMed Web of Science ®Google Scholar
• Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald NQ, Butler A, Jones D, Raine K, Latimer C, Santos CR, Nohadani M, Eklund AC, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal PA, Swanton C. 2012. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892.
   PubMed Web of Science ®Google Scholar
• Goel HL, Sayeed A, Breen M, Zarif MJ, Garlick DS, Leav I, Davis RJ, Fitzgerald TJ, Morrione A, Hsieh CC, Liu Q, Dicker AP, Altieri DC, Languino LR. 2013. β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1. J Cell Physiol 228:1601–1609.
   Google Scholar
• Golubovskaya VM. 2013. FAK and Nanog cross talk with p53 in cancer stem cells. Anticancer Agents Med Chem 13:576–580.
   Google Scholar
• Gorges TM, Tinhofer I, Drosch M, Röse L, Zollner TM, Krahn T, von Ahsen O. 2012. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer 12:178.
   PubMed Web of Science ®Google Scholar
• Harada H, Inoue M, Itasaka S, Hirota K, Morinibu A, Shinomiya K, Zeng L, Ou G, Zhu Y, Yoshimura M, McKenna WG, Muschel RJ, Hiraoka M. 2012. Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels. Nat Commun 3:783.
   PubMed Web of Science ®Google Scholar
• Harkness L, Novikov SM, Beermann J, Bozhevolnyi SI, Kassem M. 2012. Identification of abnormal stem cells using Raman spectroscopy. Stem Cells Dev 21:2152–2159.
   Google Scholar
• Helbig L, Koi L, Brüchner K, Gurtner K, Hess-Stumpp H, Unterschemmann K, Pruschy M, Baumann M, Yaromina A, Zips D. 2014. Hypoxia-inducible factor pathway inhibition resolves tumor hypoxia and improves local tumor control after single-dose irradiation. Int J Radiat Oncol Biol Phys 88:159–166.
   PubMed Web of Science ®Google Scholar
• Hewitt HB, Wilson CW. 1959. A survival curve for mammalian cells irradiated in vivo. Nature 183:1060–1061.
   PubMed Web of Science ®Google Scholar
• Hill RP, Milas L. 1989. The proportion of stem cells in murine tumors. Int J Radiat Oncol Biol Phys 16:513–518.
   PubMed Web of Science ®Google Scholar
• Hwang-Verslues WW, Kuo WH, Chang PH, Pan CC, Wang HH, Tsai ST, Jeng YM, Shew JY, Kung JT, Chen CH, Lee EY, Chang KJ, Lee WH. 2009. Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS One 4(12):e8377.
   PubMedGoogle Scholar
• Hönscheid P, Datta K, Muders MH. 2014. Autophagy: Detection, regulation and its role in cancer and therapy response. Int J Radiat Biol 90:628–635.
   PubMed Web of Science ®Google Scholar
• de Jong MC, Pramana J, van der Wal JE, Lacko M, Peutz-Kootstra CJ, de Jong JM, Takes RP, Kaanders JH, van der Laan BF, Wachters J, Jansen JC, Rasch CR, van Velthuysen ML, Grénman R, Hoebers FJ, Schuuring E, van den Brekel MW, Begg AC. 2010. CD44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res 16:5329–5338.
   PubMed Web of Science ®Google Scholar
• Kasimir-Bauer S, Hoffmann O, Wallwiener D, Kimmig R, Fehm T. 2012. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells. Breast Cancer Res 14:R15.
   PubMed Web of Science ®Google Scholar
• Kawamoto A, Tanaka K, Saigusa S, Toiyama Y, Morimoto Y, Fujikawa H, Iwata T, Matsushita K, Yokoe T, Yasuda H, Inoue Y, Miki C, Kusunoki M. 2012. Clinical significance of radiation-induced CD133 expression in residual rectal cancer cells after chemoradiotherapy. Exp Ther Med 3:403–409.
   PubMed Web of Science ®Google Scholar
• Kelly CJ, Hussien K, Fokas E, Kannan P, Shipley RJ, Ashton TM, Stratford M, Pearson N, Muschel RJ. 2014. Regulation of O2 consumption by the PI3K and mTOR pathways contributes to tumor hypoxia. Radiother Oncol (DOI: 10.1016/j.radonc.2014.02.007).
   Google Scholar
• Kim KJ, Lee KH, Kim HS, Moon KS, Jung TY, Jung S, Lee MC. 2011. The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas. Neuropathology 31:494–502.
   PubMed Web of Science ®Google Scholar
• Klein CA. 2009. Parallel progression of primary tumours and metastases. Nat Rev Cancer 9:302–312.
   PubMed Web of Science ®Google Scholar
• Koristka S, Cartellieri M, Arndt C, Bippes CC, Feldmann A, Michalk I, Wiefel K, Stamova S, Schmitz M, Ehninger G, Bornhäuser M, Bachmann M. 2013. Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B. J Autoimmun 42: 105–116.
   PubMed Web of Science ®Google Scholar
• Koristka S, Cartellieri M, Theil A, Feldmann A, Arndt C, Stamova S, Michalk I, Töpfer K, Temme A, Kretschmer K, Bornhäuser M, Ehninger G, Schmitz M, Bachmann M. 2012. Retargeting of human regulatory T cells by single-chain bispecific antibodies. J Immunol 188:1551–1558.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Giatromanolaki A, Tsakmaki V, Danielidis V, Sivridis E. 2012. Cancer stem cell phenotype relates to radio- chemotherapy outcome in locally advanced squamous cell head-neck cancer. Br J Cancer 106:846–853.
   PubMed Web of Science ®Google Scholar
• Kreso A, Dick JE. 2014. Evolution of the Cancer Stem Cell Model. Cell Stem Cell 14:275–291.
   PubMed Web of Science ®Google Scholar
• Kwon GY, Ha H, Ahn G, Park SY, Huh SJ, Park W. 2007. Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell carcinoma in patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 69:1150–1156.
   Google Scholar
• Kurth I, Peitzsch C, Baumann M, Dubrovska A. 2014. The role of cancer stem cells in tumor radioresistance. In: Rajasekhar VK, editor. Cancer stem cells. Hoboken, NJ: John Wiley & Sons.
   Google Scholar
• Li H, Tang DG. 2011. Prostate cancer stem cells and their potential roles in metastasis. J Surg Oncol 103:558–562.
   PubMed Web of Science ®Google Scholar
• Liu SK, Bham SA, Fokas E, Beech J, Im J, Cho S, Harris AL, Muschel RJ. 2011. Delta-like ligand 4-notch blockade and tumor radiation response. J Natl Cancer Inst 103:1778–1798.
   Google Scholar
• Liu HK, Wang Y, Belz T, Bock D, Takacs A, Radlwimmer B, Barbus S, Reifenberger G, Lichter P, Schütz G. 2010. The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiation. Genes Dev 24:683–695.
   PubMedGoogle Scholar
• Lomnytska MI, Becker S, Hellman K, Hellström AC, Souchelnytskyi S, Mints M, Hellman U, Andersson S, Auer G. 2010. Diagnostic protein marker patterns in squamous cervical cancer. Proteomics Clin Appl 4:17–31.
   PubMed Web of Science ®Google Scholar
• Lundholm L, Hååg P, Juntti T, Lewensohn R, Viktorsson K. 2014. Phosphoprotein analysis reveals MEK inhibition as a way to target non-small cell lung cancer tumor initiating cells. Int J Radiat Biol 90:718–726.
   PubMed Web of Science ®Google Scholar
• Mantoni TS, Lunardi S, Al-Assar O, Masamune A, Brunner TB. 2011. Pancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signaling. Cancer Res 71:3453–3458.
   Google Scholar
• Marie-Egyptienne DT, Lohse I, Hill RP. 2013. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia. Cancer Lett 341:63–72.
   PubMed Web of Science ®Google Scholar
• Metellus P, Nanni-Metellus I, Delfino C, Colin C, Tchogandjian A, Coulibaly B, Fina F, Loundou A, Barrie M, Chinot O, Ouafik L, Figarella-Branger D. 2011. Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: A prospective patient cohort at a single institution. Ann Surg Oncol 18:2937–2945.
   Google Scholar
• Mints M, Souchelnytskyi S. 2011. Proteomic strategy for detection of circulating tumor cell surface antigens. Exp Oncol 33:193–195.
   Google Scholar
• Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T, Hamou MF, de Tribolet N, Regli L, Wick W, Kouwenhoven MC, Hainfellner JA, Heppner FL, Dietrich PY, Zimmer Y, Cairncross JG, Janzer RC, Domany E, Delorenzi M, Stupp R, Hegi ME. 2008. Stem cell-related ‘self-renewal’ signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 26:3015–3024.
   PubMedGoogle Scholar
• Mäbert K, Cojoc M, Peitzsch C, Kurth I, Souchelnytskyi S, Dubrovska A. 2014. Cancer biomarker discovery: Current status and future perspectives. Int J Radiat Biol 90:659–677.
   PubMed Web of Science ®Google Scholar
• Nakata S, Phillips E, Goidts V. 2014. Emerging role for leucine-rich repeat-containing G-protein-coupled receptors LGR5 and LGR4 in cancer stem cells. Cancer Manag Res 6:171–180.
   Web of Science ®Google Scholar
• O’Hayre M, Degese MS, Gutkind JS. 2014. Novel insights into G protein and G protein-coupled receptor signaling in cancer. Curr Opin Cell Biol 27C:126–135.
   Google Scholar
• Pajonk F, Vlashi E, McBride WH. 2010. Radiation resistance of cancer stem cells: The 4 R's of radiobiology revisited. Stem Cells 28:639–648.
   PubMed Web of Science ®Google Scholar
• Pallini R, Ricci-Vitiani L, Banna GL, Signore M, Lombardi D, Todaro M, Stassi G, Martini M, Maira G, Larocca LM, De Maria R. 2008. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res. 24:8205–8212.
   Google Scholar
• Park DM, Jung J, Masjkur J, Makrogkikas S, Ebermann D, Saha S, Rogliano R, Paolillo N, Pacioni S, McKay RD, Poser S, Androutsellis-Theotokis A. 2013. Hes3 regulates cell number in cultures from glioblastoma multiforme with stem cell characteristics. Sci Rep 3:1095.
   Google Scholar
• Peickert S, Waurig J, Dittfeld C, Dietrich A, Garbe Y, Kabus L, Baumann M, Grade M, Ried T, Kunz-Schughart LA. 2012. Rapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo. Lab Invest 92:1607–1622.
   Google Scholar
• Peitzsch C, Kurth I, Kunz-Schughart L, Baumann M, Dubrovska A. 2013. Discovery of the cancer stem cell related determinants of radioresistance. Radiother Oncol 108:378–387.
   PubMed Web of Science ®Google Scholar
• Peitzsch C, Perrin R, Hill RP, Dubrovska A, Kurth I. 2014. Hypoxia as a Biomarker for Radioresistant Cancer Stem Cells. Int J Radiat Biol in press.
   Google Scholar
• Pilati P, Mocellin S, Bertazza L, Galdi F, Briarava M, Mammano E, Tessari E, Zavagno G, Nitti D. 2012. Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis. Ann Surg Oncol 19: 402–408.
   Google Scholar
• Poser SW, Park DM, Androutsellis-Theotokis A. 2014. The STAT3- Ser/Hes3 signaling axis in cancer. Front Biosci (Landmark Ed) 19:718–726.
   Google Scholar
• Poser I, Sarov M, Hutchins JR, Hériché JK, Toyoda Y, Pozniakovsky A, Weigl D, Nitzsche A, Hegemann B, Bird AW, Pelletier L, Kittler R, Hua S, Naumann R, Augsburg M, Sykora MM, Hofemeister H, Zhang Y, Nasmyth K, White KP, Dietzel S, Mechtler K, Durbin R, Stewart AF, Peters JM, Buchholz F, Hyman AA. 2008. BAC TransgeneOmics: A high-throughput method for exploration of protein function in mammals. Nat Methods 5:409–415.
   PubMed Web of Science ®Google Scholar
• Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter CR, Calhoun-Davis T, Li H, Palapattu GS, Pang S, Lin K, Huang J, Ivanov I, Li W, Suraneni MV, Tang DG. 2012. The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell 10:556–569.
   PubMed Web of Science ®Google Scholar
• Rentala S, Chintala R, Guda M, Chintala M, Komarraju AL, Mangamoori LN. 2013. Atorvastatin inhibited Rho-associated kinase 1 (ROCK1) and focal adhesion kinase (FAK) mediated adhesion and differentiation of CD133 + CD44+ prostate cancer stem cells. Biochem Biophys Res Commun 441:586–592.
   Google Scholar
• Rycaj K, Tang DG. 2014. Cancer stem cells and radioresistance. Int J Radiat Biol 90:615–621.
   PubMed Web of Science ®Google Scholar
• Schober M, Fuchs E. 2011. Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling. Proc Natl Acad Sci USA 108:10544–10549.
   PubMed Web of Science ®Google Scholar
• Skvortsov S, Debbage P, Cho WC, Lukas P, Skvortsova I. 2014a. Putative biomarkers and therapeutic targets associated with radiation resistance. Expert Rev Proteomics 11:207–214.
   Web of Science ®Google Scholar
• Skvortsov S, Debbage P, Skvortsova I. 2014b. Proteomics of cancer stem cells. Int J Radiat Biol 90:653–658.
   Web of Science ®Google Scholar
• Sinha N, Mukhopadhyay S, Das DN, Panda PK, Bhutia SK. 2013. Relevance of cancer initiating/stem cells in carcinogenesis and therapy resistance in oral cancer. Oral Oncol 49:854–862.
   PubMed Web of Science ®Google Scholar
• Smit JK, Faber H, Niemantsverdriet M, Baanstra M, Bussink J, Hollema H, van Os RP, Plukker JT, Coppes RP. 2013. Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markers. Radiother Oncol 107:434–441.
   PubMed Web of Science ®Google Scholar
• Stanton MJ, Dutta S, Zhang H, Polavaram NS, Leontovich AA, Hönscheid P, Sinicrope FA, Tindall DJ, Muders MH, Datta K. 2013. Autophagy control by the VEGF-C/NRP-2 axis in cancer and its implication for treatment resistance. Cancer Res 73:160–171.
   Google Scholar
• Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T, Kassam AB, Pollack IF, Park DM. 2009. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28: 3949–3959.
   PubMed Web of Science ®Google Scholar
• Sottoriva A, Spiteri I, Piccirillo SG, Touloumis A, Collins VP, Marioni JC, Curtis C, Watts C, Tavaré S. 2013. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci USA 110:4009–4014.
   PubMed Web of Science ®Google Scholar
• Sprenger T, Conradi LC, Beissbarth T, Ermert H, Homayounfar K, Middel P, Rüschoff J, Wolff HA, Schüler P, Ghadimi BM, Rödel C, Becker H, Rödel F, Liersch T. 2013. Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival. Cancer 119:26–35.
   PubMed Web of Science ®Google Scholar
• Sun YF, Xu Y, Yang XR, Guo W, Zhang X, Qiu SJ, Shi RY, Hu B, Zhou J, Fan J. 2013. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology 57:1458–1468.
   PubMed Web of Science ®Google Scholar
• Sung CO, Park W, Choi YL, Ahn G, Song SY, Huh SJ, Bae DS, Kim BG, Lee JH. 2010. Prognostic significance of CD24 protein expression in patients treated with adjuvant radiotherapy after radical hysterectomy for cervical squamous cell carcinoma. Radiother Oncol 95:359–364.
   Google Scholar
• Tang DG. 2012. Understanding cancer stem cell heterogeneity and plasticity. Cell Res 22:457–472.
   PubMed Web of Science ®Google Scholar
• Tinhofer I, Saki M, Niehr F, Keilholz U, Budach V. 2014. Cancer stem cell characteristics of circulating tumor cells. Int J Radiat Biol 90:622–627.
   PubMed Web of Science ®Google Scholar
• Trautmann F, Cojoc M, Kurth I, Melin N, Bouchez LC, Dubrovska A, Peitzsch C. 2014. CXCR4 as biomarker for radioresistant cancer stem cells. Int J Radiat Biol 90:687–699.
   PubMed Web of Science ®Google Scholar
• Trott KR. 1994. Tumour stem cells: The biological concept and its application in cancer treatment. Radiother Oncol 30:1–5.
   PubMed Web of Science ®Google Scholar
• Uckermann O, Galli R, Anger M, Herold-Mende C, Koch E, Schackert G, Steiner G, Kirsch M. 2014. Label-free identification of the glioma stem-like cell fraction using Fourier-transform infrared spectroscopy. Int J Radiat Biol 90:710–717.
   Web of Science ®Google Scholar
• Vaupel P, Mayer A. 2007. Hypoxia in cancer: Significance and impact on clinical outcome. Cancer Metastasis Rev 26:225–239.
   PubMed Web of Science ®Google Scholar
• Wang Q, Chen ZG, Du CZ, Wang HW, Yan L, Gu J. 2009. Cancer stem cell marker CD133 + tumour cells and clinical outcome in rectal cancer. Histopathology 55:284–293.
   Google Scholar
• Wermke M, Camgoz A, Paszkowski-Rogacz M, Thieme S, von Bonin M, Dahl A, Theis M, Ehninger G, Brenner S, Bornhäuser M, Buchholz F. 2013. A genome wide shRNA screen in primary human AML cells identifies ROCK1 as a novel therapeutic target. Blood 122:170.
   Google Scholar
• Wilson WR, Hay MP. 2011. Targeting hypoxia in cancer therapy. Nat Rev Cancer 11:393–410.
   PubMed Web of Science ®Google Scholar
• Wurdak H. 2012. Exploring the cancer stem cell phenotype with high-throughput screening applications. Future Med Chem 4: 1229–1241.
   Google Scholar
• Wurdak H, Zhu S, Romero A, Lorger M, Watson J, Chiang CY, Zhang J, Natu VS, Lairson LL, Walker JR, Trussell CM, Harsh GR, Vogel H, Felding-Habermann B, Orth AP, Miraglia LJ, Rines DR, Skirboll SL, Schultz PG. 2010. An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation. Cell Stem Cell 6:37–47.
   PubMedGoogle Scholar
• Yeung TM, Gandhi SC, Bodmer WF. 2011. Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. Proc Natl Acad Sci USA 108:4382–4387.
   PubMed Web of Science ®Google Scholar
• Zips D, Zöphel K, Abolmaali N, Perrin R, Abramyuk A, Haase R, Appold S, Steinbach J, Kotzerke J, Baumann M. 2012. Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. Radiother Oncol 105:21–28.
   PubMed Web of Science ®Google Scholar